Literature DB >> 6703288

Midazolam versus atropine plus pethidine as premedication in children.

S Sjövall, J Kanto, E Iisalo, J J Himberg, L Kangas.   

Abstract

The effects of oral midazolam or intramuscular atropine and pethidine used as premedication in two groups of 35 children over 5 years of age were studied. There was some evidence that the anxiolytic effect of midazolam was rather better than that of atropine plus pethidine, but, in other respects, subjective assessments in the two patient groups were similar. Intramuscular atropine caused tachycardia and subjective side-effects, nevertheless children appear to require anticholinergics during premedication because of excessive salivary secretion, especially during extubation. Oral midazolam is a new anxiolytic drug which can be used as an alternative to existing premedicant drugs, but, in children, it should still be combined with an anticholinergic agent. No correlation between serum levels of midazolam or atropine and their clinical effects was found.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6703288     DOI: 10.1111/j.1365-2044.1984.tb07231.x

Source DB:  PubMed          Journal:  Anaesthesia        ISSN: 0003-2409            Impact factor:   6.955


  7 in total

1.  Premedication of children with oral midazolam.

Authors:  C O McMillan; I A Spahr-Schopfer; N Sikich; E Hartley; J Lerman
Journal:  Can J Anaesth       Date:  1992-07       Impact factor: 5.063

Review 2.  Anaesthetic premedication: aims, assessment and methods.

Authors:  T H Madej; R T Paasuke
Journal:  Can J Anaesth       Date:  1987-05       Impact factor: 5.063

3.  A pilot study of the efficacy of oral midazolam for sedation in pediatric dental patients.

Authors:  D A Haas; S A Nenniger; R Yacobi; J G Magathan; H A Grad; P E Copp; M D Charendoff
Journal:  Anesth Prog       Date:  1996

4.  Comparison of the effects of atropine in vivo and ex vivo (radioreceptor assay) after oral and intramuscular administration to man.

Authors:  C Volz-Zang; T Waldhäuser; B Schulte; D Palm
Journal:  Eur J Clin Pharmacol       Date:  1995       Impact factor: 2.953

5.  Tofisopam and midazolam: differences in clinical effects and in changes of CSF monoamine metabolites.

Authors:  M Hovi-Viander; J Kanto; H Scheinin; M Scheinin
Journal:  Br J Clin Pharmacol       Date:  1985-11       Impact factor: 4.335

Review 6.  Preparing children for the operating room: psychological issues.

Authors:  T McGraw
Journal:  Can J Anaesth       Date:  1994-11       Impact factor: 5.063

Review 7.  Midazolam. A review of its pharmacological properties and therapeutic use.

Authors:  J W Dundee; N J Halliday; K W Harper; R N Brogden
Journal:  Drugs       Date:  1984-12       Impact factor: 9.546

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.